Year |
Citation |
Score |
2018 |
Mukherjee S, Griffin DH, Horn JR, Rizk SS, Nocula-Lugowska M, Malmqvist M, Kim SS, Kossiakoff AA. Engineered synthetic antibodies as probes to quantify the energetic contributions of ligand binding to conformational changes in proteins. The Journal of Biological Chemistry. PMID 29321208 DOI: 10.1074/Jbc.Ra117.000656 |
0.768 |
|
2017 |
Rizk SS, Mukherjee S, Koide A, Koide S, Kossiakoff AA. Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody. Scientific Reports. 7: 556. PMID 28373671 DOI: 10.1038/S41598-017-00728-1 |
0.579 |
|
2015 |
Rizk SS, Kouadio JL, Szymborska A, Duguid EM, Mukherjee S, Zheng J, Clevenger CV, Kossiakoff AA. Engineering synthetic antibody binders for allosteric inhibition of prolactin receptor signaling. Cell Communication and Signaling : Ccs. 13: 1. PMID 25589173 DOI: 10.1186/S12964-014-0080-8 |
0.721 |
|
2013 |
Paduch M, Koide A, Uysal S, Rizk SS, Koide S, Kossiakoff AA. Generating conformation-specific synthetic antibodies to trap proteins in selected functional states. Methods (San Diego, Calif.). 60: 3-14. PMID 23280336 DOI: 10.1016/J.Ymeth.2012.12.010 |
0.691 |
|
2012 |
Rizk SS, Misiura A, Paduch M, Kossiakoff AA. Substance P derivatives as versatile tools for specific delivery of various types of biomolecular cargo. Bioconjugate Chemistry. 23: 42-6. PMID 22175275 DOI: 10.1021/Bc200496E |
0.594 |
|
2011 |
Rizk SS, Paduch M, Heithaus JH, Duguid EM, Sandstrom A, Kossiakoff AA. Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins. Nature Structural & Molecular Biology. 18: 437-42. PMID 21378967 DOI: 10.1038/Nsmb.2002 |
0.742 |
|
2010 |
Kossiakoff AA, Rizk S. Keeping signaling in check. Structure (London, England : 1993). 18: 275-6. PMID 20223207 DOI: 10.1016/J.Str.2010.02.004 |
0.513 |
|
2010 |
Brawley CM, Uysal S, Rizk S, Luchniak A, Kossiakoff A, Rock RS. Generation of a De Novo Actin Pointed-End Binding Protein Biophysical Journal. 98: 157a. DOI: 10.1016/J.Bpj.2009.12.844 |
0.719 |
|
2010 |
Kumar R, Rizk SS, Kossiakoff AA, Im W. Molecular Modeling and Simulations of the Transmembrane Domain of Human Growth Hormone Receptor Biophysical Journal. 98: 417a. DOI: 10.1016/J.Bpj.2009.12.2254 |
0.582 |
|
2009 |
Rizk SS, Luchniak A, Uysal S, Brawley CM, Rock RS, Kossiakoff AA. An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 11011-5. PMID 19549879 DOI: 10.1073/Pnas.0904907106 |
0.707 |
|
2006 |
Rizk SS, Cuneo MJ, Hellinga HW. Identification of cognate ligands for the Escherichia coli phnD protein product and engineering of a reagentless fluorescent biosensor for phosphonates. Protein Science : a Publication of the Protein Society. 15: 1745-51. PMID 16751609 DOI: 10.1110/Ps.062135206 |
0.746 |
|
2004 |
Allert M, Rizk SS, Looger LL, Hellinga HW. Computational design of receptors for an organophosphate surrogate of the nerve agent soman. Proceedings of the National Academy of Sciences of the United States of America. 101: 7907-12. PMID 15148405 DOI: 10.1073/Pnas.0401309101 |
0.681 |
|
2002 |
Liu H, Schmidt JJ, Bachand GD, Rizk SS, Looger LL, Hellinga HW, Montemagno CD. Control of a biomolecular motor-powered nanodevice with an engineered chemical switch. Nature Materials. 1: 173-7. PMID 12618806 DOI: 10.1038/Nmat761 |
0.565 |
|
2002 |
de Lorimier RM, Smith JJ, Dwyer MA, Looger LL, Sali KM, Paavola CD, Rizk SS, Sadigov S, Conrad DW, Loew L, Hellinga HW. Construction of a fluorescent biosensor family. Protein Science : a Publication of the Protein Society. 11: 2655-75. PMID 12381848 DOI: 10.1110/Ps.021860 |
0.744 |
|
Show low-probability matches. |